A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV?

Matthews PC, Delphin M, Anderson M, Redmond J, Flanagan S, Shahmanesh M

Open source

DOI
10.1016/s2468-1253(26)00046-4
Published
2026 Jul
Container
The lancet. Gastroenterology & hepatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00046-4,
  title = {A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV?},
  author = {Matthews PC and Delphin M and Anderson M and Redmond J and Flanagan S and Shahmanesh M},
  year = {2026},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(26)00046-4},
  url = {https://doi.org/10.1016/s2468-1253(26)00046-4}
}

RIS

TY  - JOUR
TI  - A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV?
AU  - Matthews PC
AU  - Delphin M
AU  - Anderson M
AU  - Redmond J
AU  - Flanagan S
AU  - Shahmanesh M
PY  - 2026
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(26)00046-4
UR  - https://doi.org/10.1016/s2468-1253(26)00046-4
ER  - 

APA

PC, M., M, D., M, A., J, R., S, F., & M, S. (2026). A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV?. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(26)00046-4

Source records